Westside Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Westside Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	-$9.2K	–	871
2017 Q4	$9.2K	Hold	500	–	–	0.01%	583
2017 Q3	$5.13K	Sell	500 -500	-50%	-$5.61K	﹤0.01%	671
2017 Q2	$10.8K	Hold	1,000	–	–	0.01%	523
2017 Q1	$10.3K	Buy	+1,000	New	+$11.6K	﹤0.01%	498

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Westside Investment Management's SCMP Position: Q1 2018 in Review

Westside Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 500 shares — an estimated $9.2K sold.

Westside Investment Management first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $10.8K in Q2 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Westside Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Westside Investment Management sold 500 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $9.2K.
Westside Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Westside Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $10.8K in Q2 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Westside Investment Management's 13F filing for Q1 2018, filed 16 Apr 2018.